Affivant Sciences GmbH

AFFIVANT

Pharmaceutical preparations for human use, namely, for the prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations for human use comprising cell-based therapies for the treatment of oncological, neurological and immunological diseases and disorders; biologic preparations for medical and therapeutic purposes, namely, for the prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical and biological preparations for prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncological, neurological and immunological diseases and disorders;Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions;Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine and research and design relating thereto; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine;